The expression of EphA2 is up-regulated in cervical cancer and colon cancer cells, which is mediated by the metabolic changes (AMP-activated protein kinase (AMPK)–dependent metabolic reprogramming) in tumor cells. Here, EPHA2 is linked to neoplasm.